1. Home
  2. XFOR vs SPWH Comparison

XFOR vs SPWH Comparison

Compare XFOR & SPWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XFOR
  • SPWH
  • Stock Information
  • Founded
  • XFOR 2014
  • SPWH 1986
  • Country
  • XFOR United States
  • SPWH United States
  • Employees
  • XFOR N/A
  • SPWH N/A
  • Industry
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • SPWH Other Specialty Stores
  • Sector
  • XFOR Health Care
  • SPWH Consumer Discretionary
  • Exchange
  • XFOR Nasdaq
  • SPWH Nasdaq
  • Market Cap
  • XFOR 118.4M
  • SPWH 111.7M
  • IPO Year
  • XFOR N/A
  • SPWH 2014
  • Fundamental
  • Price
  • XFOR $0.50
  • SPWH $2.88
  • Analyst Decision
  • XFOR Buy
  • SPWH Buy
  • Analyst Count
  • XFOR 3
  • SPWH 6
  • Target Price
  • XFOR $3.67
  • SPWH $3.00
  • AVG Volume (30 Days)
  • XFOR 1.2M
  • SPWH 386.0K
  • Earning Date
  • XFOR 11-07-2024
  • SPWH 12-04-2024
  • Dividend Yield
  • XFOR N/A
  • SPWH N/A
  • EPS Growth
  • XFOR N/A
  • SPWH N/A
  • EPS
  • XFOR 0.09
  • SPWH N/A
  • Revenue
  • XFOR $563,000.00
  • SPWH $1,243,937,000.00
  • Revenue This Year
  • XFOR N/A
  • SPWH N/A
  • Revenue Next Year
  • XFOR $596.79
  • SPWH $0.68
  • P/E Ratio
  • XFOR $5.76
  • SPWH N/A
  • Revenue Growth
  • XFOR N/A
  • SPWH N/A
  • 52 Week Low
  • XFOR $0.47
  • SPWH $1.81
  • 52 Week High
  • XFOR $1.60
  • SPWH $5.55
  • Technical
  • Relative Strength Index (RSI)
  • XFOR 32.08
  • SPWH 54.01
  • Support Level
  • XFOR $0.47
  • SPWH $2.70
  • Resistance Level
  • XFOR $0.58
  • SPWH $2.97
  • Average True Range (ATR)
  • XFOR 0.05
  • SPWH 0.21
  • MACD
  • XFOR -0.01
  • SPWH -0.02
  • Stochastic Oscillator
  • XFOR 11.99
  • SPWH 77.65

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

About SPWH Sportsman's Warehouse Holdings Inc.

Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.

Share on Social Networks: